Direct-to-consumer genetic testing provider 23andMe Inc.launches Personal Genome Service about two years after FDA forced the firm off the health care market, but also after the firm says its close engagement with the agency improved its customer communication and quality control.
The newly launched service is supported by disease carrier tests using an FDA-cleared saliva collection device, the Oragene DX model OGD.500.001